- $416.87m
- $565.35m
- $331.50m
- 46
- 30
- 84
- 53
Annual income statement for Cerence, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 331 | 387 | 328 | 294 | 332 |
| Cost of Revenue | |||||
| Gross Profit | 223 | 286 | 231 | 199 | 244 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 309 | 327 | 512 | 322 | 911 |
| Operating Profit | 22.4 | 60.6 | -184 | -27.2 | -580 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -23 | 48.3 | -199 | -36.4 | -585 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -18.3 | 45.9 | -311 | -56.3 | -588 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -18.3 | 45.9 | -311 | -56.3 | -588 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18.3 | 45.9 | -311 | -56.3 | -588 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.209 | 1.29 | -4.24 | -1.21 | -4.35 |